TargetMol

Synephrine hydrochloride

Product Code:
 
TAR-T6688
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6688-1mL1 mL * 10 mM (in DMSO)£94.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6688-1g1g£94.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
SynephrineHCl (Oxedrine, p-Synephrine) is an agonist that acts on sympathomimetic α-adrenergic receptor (AR).
CAS:
5985-28-4
Formula:
C9H13NO2?HCl
Molecular Weight:
203.67
Pathway:
Neuroscience; GPCR/G Protein; Metabolism
Purity:
0.9963
SMILES:
C(c1ccc(cc1)O)(CNC)O.Cl
Target:
Endogenous Metabolite; Adrenergic Receptor

References

Xu W W, Zheng C C, Huang Y N, et al. Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling. Journal of Agricultural and Food Chemistry. 2018 Sep 5;66(35):9248-9258 Hong NY, et al. Biochem Biophys Res Commun, 2012, 418(4), 720-724. Xu W W, Zheng C C, Huang Y N, et al. Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling[J]. Journal of agricultural and food chemistry. 2018 Sep 5;66(35):9248-9258. Huang YT, et al. Jpn J Pharmacol, 2001, 85(2), 183-188. Ma G, et al. Planta Med, 2010, 76(10), 981-1986. Hibino T, et al. J Pharmacol Sci, 2009, 111(1), 73-81.